RHYTHM PHARMACEUTICALS INC shareholders Q3 2023

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

RHYTHM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
FOX RUN MANAGEMENT, L.L.C. 17,186$393,9890.12%
Atom Investors LP 19,386$444,4240.10%
DRIEHAUS CAPITAL MANAGEMENT LLC 274,524$6,293,4630.08%
Alkeon Capital Management 1,725,167$39,549,4530.07%
Hennion & Walsh Asset Management, Inc. 40,146$920,3470.06%
Zimmer Partners, LP 82,500$1,891,3130.05%
WEDGE CAPITAL MANAGEMENT L L P/NC 104,720$2,400,7060.05%
Hudson Bay Capital Management LP 415,000$9,513,8760.04%
ALGERT GLOBAL LLC 33,413$7660.04%
PROFUND ADVISORS LLC 27,818$637,7280.04%
ExodusPoint Capital Management, LP 152,443$3,4950.03%
GSA CAPITAL PARTNERS LLP 16,465$3770.03%
Assenagon Asset Management S.A. 407,290$9,337,1230.03%
Bellevue Group AG 73,300$1,680,4030.03%
Leucadia National 123,660$2,834,9060.02%
PRELUDE CAPITAL MANAGEMENT, LLC 16,406$376,1080.02%
GOLDMAN SACHS GROUP INC 5,160,541$118,305,4020.02%
Point72 Middle East FZE 31,181$714,8240.02%
Leucadia National 108,000$2,475,9000.02%
Rafferty Asset Management, LLC 162,804$3,732,2820.02%
External links

This page lists RHYTHM PHARMACEUTICALS INC's shareholders in Q3 2023. To view RHYTHM PHARMACEUTICALS INC's shareholder history, click here.